Innovative Technologies and Assays in Support of HIV Cure Research (ITAS-Cure) (R41/R42)

The summary for the Innovative Technologies and Assays in Support of HIV Cure Research (ITAS-Cure) (R41/R42) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Innovative Technologies and Assays in Support of HIV Cure Research (ITAS-Cure) (R41/R42): The purpose of this Funding Opportunity Announcement (FOA) is to encourage Small Business Technology Transfer (STTR) grant applications from Small Business Concerns (SBCs) that focus on the development of sensitive and quantitative assays, methods, or imaging techniques, including the development or novel applications of imaging agents or probes that can be applied to the measurement of residual HIV reservoirs in HIV-positive individuals, who are on effective antiretroviral therapy. Such technologies are required to have commercial potential. NIH is especially interested in next-generation tools and methods that can quantitate replication-competent virus or integrated provirus or distinguish HIV infected cells in situ. The new tools proposed in the application should provide substantially increased sensitivity, reproducibility, spatiotemporal resolution, and/or scalability, as compared to existing methodologies and be able to characterize the replicative capacity of HIV-infected cells and tissues. These novel technologies will aid in obtaining a fine-grained and dynamic view of the persistent HIV reservoir. In addition, NIH is interested in quantitative methods and analytical tools to assess the viral load, either replication competent or integrated provirus, in a reproducible manner so as to monitor the dynamic changes in persistent infection.
Federal Grant Title: Innovative Technologies and Assays in Support of HIV Cure Research (ITAS-Cure) (R41/R42)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-14-102
Type of Funding: Grant
CFDA Numbers: 93.286, 93.855, 93.856, 93.859
CFDA Descriptions: Discovery and Applied Research for Technological Innovations to Improve Human Health; Allergy, Immunology and Transplantation Research; Microbiology and Infectious Diseases Research; Biomedical Research and Research Training
Current Application Deadline: Jan 7, 2017
Original Application Deadline: Jan 7, 2017
Posted Date: Feb 13, 2014
Creation Date: Feb 13, 2014
Archive Date: Feb 7, 2017
Total Program Funding:
Maximum Federal Grant Award: none
Minimum Federal Grant Award: none
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Small businesses
Additional Information on Eligibility
Other Eligible Applicants include the following:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/PA-14-102.html
Grant Announcement Contact
NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants
New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Opt...
Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historic...
Understanding and Mitigating Health Disparities experienced by People with Disabilities ca...
National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Op...
Research on Bioethical Issues Related to Bionic and Robotic Device Development and Transla...
Exploratory Grants (P20) for NIBIB Quantum Projects
Nibib Research Supplements to Promote Clinical Resident Research Experiences
Innovation in Molecular Imaging Probes
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com